SMT202400482T1 - Mutanti della pneumolisina e metodi per relativo uso - Google Patents

Mutanti della pneumolisina e metodi per relativo uso

Info

Publication number
SMT202400482T1
SMT202400482T1 SM20240482T SMT202400482T SMT202400482T1 SM T202400482 T1 SMT202400482 T1 SM T202400482T1 SM 20240482 T SM20240482 T SM 20240482T SM T202400482 T SMT202400482 T SM T202400482T SM T202400482 T1 SMT202400482 T1 SM T202400482T1
Authority
SM
San Marino
Prior art keywords
methods
pneumolysin mutants
pneumolysin
mutants
Prior art date
Application number
SM20240482T
Other languages
English (en)
Italian (it)
Inventor
Rodney K Tweten
Original Assignee
The Board Of Regents Of Theuniversity Of Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Regents Of Theuniversity Of Oklahoma filed Critical The Board Of Regents Of Theuniversity Of Oklahoma
Publication of SMT202400482T1 publication Critical patent/SMT202400482T1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
SM20240482T 2014-11-21 2015-11-20 Mutanti della pneumolisina e metodi per relativo uso SMT202400482T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462082848P 2014-11-21 2014-11-21
PCT/US2015/061859 WO2016081839A1 (en) 2014-11-21 2015-11-20 Pneumolysin mutants and methods of use thereof
EP15861711.8A EP3220937B1 (en) 2014-11-21 2015-11-20 Pneumolysin mutants and methods of use thereof

Publications (1)

Publication Number Publication Date
SMT202400482T1 true SMT202400482T1 (it) 2025-01-14

Family

ID=56014598

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20240482T SMT202400482T1 (it) 2014-11-21 2015-11-20 Mutanti della pneumolisina e metodi per relativo uso

Country Status (21)

Country Link
US (1) US10562941B2 (enExample)
EP (2) EP4501949A3 (enExample)
JP (1) JP6734274B2 (enExample)
KR (1) KR102304828B1 (enExample)
CN (1) CN107106635B (enExample)
AU (1) AU2015349787B2 (enExample)
CA (1) CA2968398A1 (enExample)
DK (1) DK3220937T3 (enExample)
ES (1) ES2993430T3 (enExample)
FI (1) FI3220937T3 (enExample)
HR (1) HRP20241627T1 (enExample)
HU (1) HUE069200T2 (enExample)
LT (1) LT3220937T (enExample)
MX (1) MX381872B (enExample)
PL (1) PL3220937T3 (enExample)
PT (1) PT3220937T (enExample)
RS (1) RS66221B1 (enExample)
SI (1) SI3220937T1 (enExample)
SM (1) SMT202400482T1 (enExample)
WO (1) WO2016081839A1 (enExample)
ZA (1) ZA201703881B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181308B2 (en) 2011-03-28 2015-11-10 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
WO2018124959A2 (en) 2016-12-28 2018-07-05 Henriques Normark Birgitta Microparticles from streptococcus pneumoniae as vaccine antigens
CN110967482B (zh) * 2018-09-30 2023-04-07 重庆市畜牧科学院 一种山羊化脓隐秘杆菌感染检测试剂盒及其检测方法
CN113264999B (zh) * 2021-04-29 2023-02-28 星济生物(苏州)有限公司 中和肺炎链球菌溶血素蛋白的抗原结合蛋白及其用途
WO2023039223A1 (en) * 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines
WO2023092090A1 (en) 2021-11-18 2023-05-25 Matrivax, Inc. Immunogenic fusion protein compositions and methods of use thereof
CN115927420A (zh) * 2022-05-27 2023-04-07 贵州省畜牧兽医研究所 一种溶血素重组表达及间接elisa检测方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
JP3237842B2 (ja) 1988-12-16 2001-12-10 オランダ国 ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン
US6716432B1 (en) 1988-12-16 2004-04-06 James Cleland Paton Pneumolysin mutants and pneumococcal vaccines made therefrom
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
ATE291625T1 (de) 1995-06-07 2005-04-15 Univ Minnesota Streptococcus toxinmutanten und verfahren zu deren anwendung
EP0998557A2 (en) 1997-07-21 2000-05-10 North American Vaccine, Inc. Modified immunogenic pneumolysin, compositions and their use as vaccines
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
PL204863B1 (pl) 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
PT1140157E (pt) 1998-12-21 2009-05-06 Medimmune Inc Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
WO2004043376A2 (en) 2002-11-07 2004-05-27 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
CA2555803A1 (en) 2004-02-13 2005-08-27 Sanofi Pasteur Limited Pneumolysin derivatives
WO2005108419A1 (en) 2004-05-07 2005-11-17 Lea-Ann Kirkham Mutant cholesterol-binding cytolysin proteins
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
WO2007144647A2 (en) 2006-06-15 2007-12-21 Timothy John Mitchell Adjuvant compositions
WO2009023300A2 (en) * 2007-04-13 2009-02-19 The Board Of Regents Of The University Of Oklahoma Mutants of cholesterol-dependent cytolysins and uses thereof
CN106008679A (zh) * 2008-12-24 2016-10-12 荷兰王国卫生福利和运动部国家公共卫生和环境研究所 修饰的肺炎链球菌溶血素(ply)多肽
EP2515940A4 (en) * 2009-12-22 2013-10-09 Sanofi Pasteur Ltd Immunogenic compositions and related methods
CL2010001216A1 (es) * 2010-11-08 2011-01-28 New Tech Copper S P A Sistema para confinar el espacio sobre el electrolito en una celda de electro obtencion y evacuar los aerosoles generados, que comprende un confinador insertado en cada anodo, con un par de proyecciones flexibles y un par de perfiles en angulo, y ductos longitudinales con perforaciones sobre el nivel del electrolito.
US9181308B2 (en) 2011-03-28 2015-11-10 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
JP6397805B2 (ja) 2015-08-28 2018-09-26 東芝メモリ株式会社 半導体製造装置およびその運転方法

Also Published As

Publication number Publication date
BR112017010696A2 (pt) 2017-12-26
LT3220937T (lt) 2024-12-27
JP2017536124A (ja) 2017-12-07
US10562941B2 (en) 2020-02-18
PT3220937T (pt) 2024-11-18
EP3220937A4 (en) 2018-05-30
HUE069200T2 (hu) 2025-02-28
ES2993430T3 (en) 2024-12-30
MX2017006625A (es) 2018-01-15
DK3220937T3 (da) 2024-12-02
US20180312552A1 (en) 2018-11-01
EP3220937B1 (en) 2024-09-04
JP6734274B2 (ja) 2020-08-05
SI3220937T1 (sl) 2025-03-31
EP3220937A1 (en) 2017-09-27
KR20170083635A (ko) 2017-07-18
CN107106635A (zh) 2017-08-29
CN107106635B (zh) 2021-10-08
EP4501949A2 (en) 2025-02-05
KR102304828B1 (ko) 2021-09-27
EP4501949A3 (en) 2025-04-30
HRP20241627T1 (hr) 2025-02-14
MX381872B (es) 2025-03-13
FI3220937T3 (fi) 2024-11-29
PL3220937T3 (pl) 2025-01-27
CA2968398A1 (en) 2016-05-26
AU2015349787B2 (en) 2021-07-29
AU2015349787A1 (en) 2017-06-22
RS66221B1 (sr) 2024-12-31
WO2016081839A1 (en) 2016-05-26
ZA201703881B (en) 2021-10-27

Similar Documents

Publication Publication Date Title
EP3285633A4 (en) STEERING MICROENDOSCOPE
IL264454A (en) Novel compositions, uses and methods for making them
DK3212502T3 (da) Luftfartøj med flere rotorer
HUE066468T2 (hu) Idegnyugtató norketamin vegyületek és eljárások
DK3172213T3 (da) Makrocykliske kinasehæmmere og anvendelser deraf
GB2524479B (en) Testing rig
DK3155209T3 (da) Brøndværktøj med dobbeltfunktion
SMT202400482T1 (it) Mutanti della pneumolisina e metodi per relativo uso
DK3233105T3 (da) Hidtil ukendt kombination og anvendelse
SG11201704473WA (en) New methods and uses
PL3092003T3 (pl) Nowe przeciwciało przeciw netrynie-1
EP2998732C0 (en) ANALYSIS PROCESS
LT3256486T (lt) Grifitzino mutantai
IL258381A (en) Oil compositions and methods of making
IL252086A0 (en) Novel methods
PT3126452T (pt) Corantes diazo e suas misturas
NO3050465T3 (no) Seating
DK3212037T3 (da) Siddemøbel
DK3096613T3 (da) Forbedret måttestruktur med insekticid
DK3359183T3 (da) Polyepitop-konstrukter til anvendelse i immunoterapy
DE112016001950A5 (de) Sitzgruppe
HUE045174T2 (hu) Parenterális készítmények és alkalmazásuk
ES1123006Y (es) Almohada
BR112018000205A2 (pt) oxiesteróis e métodos de uso destes
TH149084B (th) องค์ประกอบไอโซมอลโตโอลิโกแซคคาไรด์ที่มีไอโซมอลทูโลส วิธีสำหรับการเตรียมสิ่งเดียวกัน และการใช้ ของมัน